This inventor holds 1 USPTO granted patent. Top assignee: Seikagaku Corporation. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Hiroki Ishikawa: Innovator in Therapeutic Solutions
Introduction
Hiroki Ishikawa is a notable inventor based in Kashiwa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of herniated intervertebral discs. His innovative approach has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Hiroki Ishikawa holds a patent for a therapeutic agent aimed at treating herniated intervertebral discs. This pharmaceutical composition includes a glycosaminoglycan degrading enzyme, specifically chondroitinase ABC, which is effective in dissolving the nucleus pulposus that exists epidurally. This invention represents a significant advancement in the treatment options available for patients with this condition.
Career Highlights
Ishikawa is associated with Seikagaku Corporation, a company known for its focus on innovative therapeutic solutions. His work at the company has allowed him to develop and refine his ideas, leading to impactful inventions in the medical field.
Collaborations
Hiroki Ishikawa collaborates with Yutaka Nohara, a fellow professional in the industry. Their partnership exemplifies the importance of teamwork in driving innovation and advancing medical research.
Conclusion
Hiroki Ishikawa's contributions to the field of pharmaceuticals, particularly through his patent for a therapeutic agent for herniated intervertebral discs, highlight his role as an influential inventor. His work continues to pave the way for new treatment options that can benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile